Correlation
The correlation between APLS and SPY is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
APLS vs. SPY
Compare and contrast key facts about Apellis Pharmaceuticals, Inc. (APLS) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: APLS or SPY.
Performance
APLS vs. SPY - Performance Comparison
Loading data...
Key characteristics
APLS:
-1.09
SPY:
0.70
APLS:
-1.75
SPY:
1.02
APLS:
0.79
SPY:
1.15
APLS:
-0.71
SPY:
0.68
APLS:
-1.72
SPY:
2.57
APLS:
33.78%
SPY:
4.93%
APLS:
53.78%
SPY:
20.42%
APLS:
-82.47%
SPY:
-55.19%
APLS:
-81.86%
SPY:
-3.55%
Returns By Period
In the year-to-date period, APLS achieves a -46.94% return, which is significantly lower than SPY's 0.87% return.
APLS
-46.94%
-15.69%
-50.10%
-56.87%
-25.80%
-12.86%
N/A
SPY
0.87%
5.54%
-1.56%
13.18%
14.25%
15.81%
12.73%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
APLS vs. SPY — Risk-Adjusted Performance Rank
APLS
SPY
APLS vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Apellis Pharmaceuticals, Inc. (APLS) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
APLS vs. SPY - Dividend Comparison
APLS has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.22%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
APLS Apellis Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.22% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
APLS vs. SPY - Drawdown Comparison
The maximum APLS drawdown since its inception was -82.47%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for APLS and SPY.
Loading data...
Volatility
APLS vs. SPY - Volatility Comparison
Apellis Pharmaceuticals, Inc. (APLS) has a higher volatility of 15.97% compared to SPDR S&P 500 ETF (SPY) at 4.86%. This indicates that APLS's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...